Beta-adrenergic blockade in hypertension.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D000804:Angiotensin II / Q000097:blood; D000818:Animals; D001921:Brain / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D007677:Kidney Function Tests; D011217:Practolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012083:Renin / Q000097:blood
D000319:Adrenergic beta-Antagonists; D000804:Angiotensin II; D000526:Alprenolol; D011433:Propranolol; D012083:Renin; D011217:Practolol